OGN vs. LLY

In the year-to-date period, OGN achieves a 11.25% return, which is significantly lower than LLY's 25.57% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current OGN Sharpe Ratio is 1.16, which is higher than the LLY Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of OGN and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

OGN's dividend yield for the trailing twelve months is around 7.42%, more than LLY's 0.72% yield.

The maximum OGN drawdown since its inception was -69.56%, roughly equal to the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for OGN and LLY. For additional features, visit the drawdowns tool.

Organon & Co. (OGN) and Eli Lilly and Company (LLY) have volatilities of 11.18% and 10.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Organon & Co. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.